Sponsored Videos

Britton Jimenez, SVP of Sales and Marketing at Codexis, explains how the ECO Synthesis® Manufacturing Platform overcomes the limitations in scalability and sustainability that currently challenge the RNA therapeutics industry.

A long-term, trust-based CDMO partnership can support cell and gene therapy developers from early process development through GMP manufacturing and commercial supply.

Jonathan Haigh, Head of UK Sites, FUJIFILM Biotechnologies, explores how advanced technologies are being used to reduce risk and strengthen global supply chains for biologics.

Biopharmaceutical manufacturers can strategically choose between fed-batch and continuous manufacturing to balance scalability, flexibility, and market demand across the product lifecycle.

Discover how data governance and AI are transforming biologics manufacturing, from ensuring patient safety to improving process efficiency. Sundar Ramanan, PhD, MBA, Chief Quality Officer at Enzene, shares insights on leveraging data for quality, compliance, and collaboration between CDMOs and biotech innovators.

Scientific experts Katarzyna Darmochwal, PhD, and Carmen Sweeney, PhD, discuss the latest regulatory expectations for the analytical testing of biologics products. They explain why regulatory success depends not only on compliance, but also on the precision, reliability, and depth of scientific understanding behind every test method.

David McErlane, Group President of Biologics at Catalent, shares how integrated expertise in biologics helps simplify complexity, accelerate development, and deliver therapies to patients faster.

Saleem Farooqui of Fresenius Kabi explains how the company is addressing today’s pharmaceutical manufacturing needs. Watch this video to learn how these capabilities can help bring products to market successfully.

A new partnership between MilliporeSigma, the Life Science Business of Merck KGaA, Darmstadt, Germany, and Simtra BioPharma Solutions is delivering streamlined ADC solutions that simplify the supply chain, accelerate patient access to vital treatments, and offer customers expert support.

Rentschler Biopharma is evolving its CDMO capabilities through strategic partnerships, infrastructure investments, and sustainability initiatives to better support clients' complex biologics programs.

Steve Griffiths, Global VP of Business Development at GCS, discusses the essential environmental factors involved in cleanroom construction. Viewers will gain insight into the decisions that influence sustainability from selecting materials to optimizing energy use.

Christine S. Yore of Ecolab discusses products and solutions that help pharmaceutical companies address sustainability and cost challenges, along with other key issues in today’s market.

Innovative Fully-Connected Continuous Manufacturing™ technology and advanced facilities are revolutionizing biomanufacturing and driving cost efficiency, especially in monoclonal antibody production.

Christiane Bardroff, Chief Operating Officer and Patrick Meyer Global Head of Business Development—both at Rentschler Biopharma SE—share their insights into the company’s client-centric approach.

Benedikt von Braunmühl, CEO of Rentschler Biopharma, discusses the company's strategic shift toward biologics CDMO services.

Why are walk-on ceilings critical in cleanroom environments? This video breaks down their key benefits, types, and safety requirements to help you understand how they enhance cleanroom functionality. Learn about load considerations, installation challenges, and future innovations shaping the industry. Whether you're designing a cleanroom or upgrading an existing one, this video provides expert insights to guide your decisions.

Dr Himanshu Gadgil, CEO, Enzene Biosciences Ltd., describes the rationale for expanding its services, including its patented EnzeneX™ continuous manufacturing technology platform, to emerging innovative, US-based biotech firms looking to benefit from the in-depth expertise in continuous manufacturing.

Christoph Winterhalter, Chief Business Officer of AGC Biologics, highlights trends in single-use technology, the CDMO’s new fill-finish capabilities, facility expansions, the potential impact of the U.S. Biosecure Act, and the growing cell and gene market.

In this interview, Jakob Liderfelt, Product Manager at Cytiva, discusses main challenges faced during chromatography process development for mAbs and mAb variants such as fragments and bispecific antibodies. Then, he shares his top tips for addressing challenges associated with mAb aggregates removal and separation of homo and heterodimers.

Matthew McClorey, President of CritiTech Particle Engineering Solutions, shares his insights at AAPS.

In silico process development for chromatography is a paradigm-shifting approach that redefines the routine work of process development scientists. But what does it actually mean to perform process development in silico? Do I need to be a math expert? Where is modeling applicable? Will I not set foot in the lab ever again?

In this video, Emma Lind, Product Manager for Chromatography Resins at Cytiva answers questions from BioPharm International about the challenges faced by process developers working with recombinant proteins.

Zachary Welch, Parker Bioscience, highlights single-use bioprocessing solutions presented at INTERPHEX 2022. Watch this video for insight regarding: